Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic acid + pantothenic acid (often formulated using its stable provitamin form, panthenol or dexpanthenol) is a synergistic topical combination widely utilized in dermatological, cosmetic, and medical device formulations to promote skin hydration, barrier repair, and wound healing. Hyaluronic acid, a naturally occurring glycosaminoglycan, acts as a powerful humectant that binds water to plump the skin and interacts with the CD44 receptor to stimulate epidermal regeneration. Pantothenic acid, converted from topically applied panthenol, serves as a key precursor for coenzyme A (CoA) biosynthesis, which is essential for lipid synthesis, fibroblast proliferation, and maintaining stratum corneum integrity. Together, this combination accelerates re-epithelialization, reduces transepidermal water loss (TEWL), and mitigates cellular senescence, making it a staple in anti-aging and post-procedure skin recovery regimens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid + pantothenic acid.